SIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox

MT Newswires Live

2025/01/02

SIGA Technologies (SIGA) said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms (28.7 pounds).

The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.

SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.

Shares of SIGA were up 6% in recent Thursday premarket activity.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2500925779"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2500925779\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2500925779?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-02 21:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2500925779","market":"fut","top_or_hot":-1,"title":"SIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox","media":"MT Newswires Live","content":"<html><body><p> SIGA Technologies (SIGA) said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms (28.7 pounds).</p><p>The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.</p><p>SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.</p><p>Shares of SIGA were up 6% in recent Thursday premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-02 21:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> SIGA Technologies (SIGA) said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms (28.7 pounds).</p><p>The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.</p><p>SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.</p><p>Shares of SIGA were up 6% in recent Thursday premarket activity.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SIGA","symbol_name":"SIGA Technologies Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2500925779","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2500925779","pubTimestamp":1735823708,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"SIGA Technologies  said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms .The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.Shares of SIGA were up 6% in recent Thursday premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SIGA":"SIGA Technologies Inc","BK4007":"制药","BK4583":"猴痘概念"},"translate_title":"SIGA Technologies表示日本药品监管机构批准其针对天花、MPox、牛痘的抗病毒治疗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIGA":1},"content_text":"SIGA Technologies (SIGA) said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms (28.7 pounds).The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.Shares of SIGA were up 6% in recent Thursday premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}